 |
The Journal of Neuroscience, February 22, 2006, 26(8):2358-2368; doi:10.1523/JNEUROSCI.3819-05.2006
Previous Article
Neurobiology of Disease
Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic Mice
Lawrence Wrabetz,1 *
Maurizio DAntonio,1 *
Maria Pennuto,1
Gabriele Dati,1
Elisa Tinelli,1
Pietro Fratta,1
Stefano Previtali,2
Daniele Imperiale,1
Jurgen Zielasek,3
Klaus Toyka,3
Robin L. Avila,4
Daniel A. Kirschner,4
Albee Messing,5
M. Laura Feltri,1 and
Angelo Quattrini2
1DIBIT and 2Department of Neurology, San Raffaele Scientific Institute, 20132 Milano, Italy, 3Department of Neurology, University of Würzburg, D97080 Würzburg, Germany, 4Biology Department, Boston College, Chestnut Hill, Massachusetts 02467, and 5Waisman Center and Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53706
Correspondence should be addressed to Lawrence Wrabetz, San Raffaele Scientific Institute, DIBIT, Via Olgettina 58, 20132 Milan, Italy. Email: l.wrabetz{at}hsr.it
Missense mutations in 22 genes account for one-quarter of CharcotMarieTooth (CMT) hereditary neuropathies. Myelin Protein Zero (MPZ, P0) mutations produce phenotypes ranging from adult demyelinating (CMT1B) to early onset [Déjérine-Sottas syndrome (DSS) or congenital hypomyelination] to predominantly axonal neuropathy, suggesting gain of function mechanisms. To test this directly, we produced mice in which either the MpzS63C (DSS) or MpzS63del (CMT1B) transgene was inserted randomly, so that the endogenous Mpz alleles could compensate for any loss of mutant P0 function. We show that either mutant allele produces demyelinating neuropathy that mimics the corresponding human disease. However, P0S63C creates a packing defect in the myelin sheath, whereas P0S63del does not arrive to the myelin sheath and is instead retained in the endoplasmic reticulum, where it elicits an unfolded protein response (UPR). This is the first evidence for UPR in association with neuropathy and provides a model to determine whether and how mutant proteins can provoke demyelination from outside of myelin.
Key words: CharcotMarieTooth neuropathy; myelin protein zero; packing; Schwann cell; traffic; transgene
Received Sept. 9, 2005;
revised Jan. 17, 2006;
accepted Jan. 17, 2006.
Correspondence should be addressed to Lawrence Wrabetz, San Raffaele Scientific Institute, DIBIT, Via Olgettina 58, 20132 Milan, Italy. Email: l.wrabetz{at}hsr.it
This article has been cited by other articles:

|
 |

|
 |
 
M. Grandis, T. Vigo, M. Passalacqua, M. Jain, S. Scazzola, V. La Padula, M. Brucal, F. Benvenuto, L. Nobbio, A. Cadoni, et al.
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations
Hum. Mol. Genet.,
July 1, 2008;
17(13):
1877 - 1889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Shy, C. Siskind, E. R. Swan, K. M. Krajewski, T. Doherty, D. R. Fuerst, P. J. Ainsworth, R. A. Lewis, S. S. Scherer, and A. F. Hahn
CMT1X phenotypes represent loss of GJB1 gene function
Neurology,
March 13, 2007;
68(11):
849 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Timmerman and D. N. Herrmann
A "nerve" ending story in the identification of mutations in Charcot-Marie-Tooth neuropathy.
Neurology,
October 10, 2006;
67(7):
1114 - 1115.
[Full Text]
[PDF]
|
 |
|
|